VOR
Vor Biopharma Inc.
NASDAQ · Healthcare · Biotechnology · US
$18.04
+0.06%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-313.6%
Return on equity
130.5%
Return on assets
74.5%
Return on invested capital
0.00x
Asset turnover
-$140.4M
Cash from operations
$7.88
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026